Nu Skin Enterprises
Market Cap
US$2.8b
Last Updated
2021/04/17 22:43 UTC
Data Sources
Company Financials +
Executive Summary
Nu Skin Enterprises, Inc. develops and distributes personal care and wellness products worldwide. More Details
Rewards
Risk Analysis
NUS passed our risk checks.
Snowflake Analysis
Solid track record with excellent balance sheet and pays a dividend.
Similar Companies
Share Price & News
How has Nu Skin Enterprises's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: NUS is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 7% a week.
Volatility Over Time: NUS's weekly volatility (7%) has been stable over the past year.
Market Performance
7 Day Return
2.3%
NUS
2.8%
US Personal Products
1.3%
US Market
1 Year Return
113.3%
NUS
79.2%
US Personal Products
53.9%
US Market
Return vs Industry: NUS exceeded the US Personal Products industry which returned 79.2% over the past year.
Return vs Market: NUS exceeded the US Market which returned 53.9% over the past year.
Shareholder returns
NUS | Industry | Market | |
---|---|---|---|
7 Day | 2.3% | 2.8% | 1.3% |
30 Day | -1.1% | 4.8% | 5.3% |
90 Day | -4.8% | 19.2% | 8.9% |
1 Year | 120.3%113.3% | 80.3%79.2% | 56.6%53.9% |
3 Year | -18.2%-25.5% | 75.9%68.9% | 64.4%53.6% |
5 Year | 58.5%36.9% | 110.4%93.1% | 120.4%95.7% |
Long-Term Price Volatility Vs. Market
How volatile is Nu Skin Enterprises's share price compared to the market and industry in the last 5 years?
Simply Wall St News
6 days ago | Simply Wall St
A Look At The Intrinsic Value Of Nu Skin Enterprises, Inc. (NYSE:NUS)2 weeks ago | Simply Wall St
Nu Skin Enterprises, Inc. (NYSE:NUS) On An Uptrend: Could Fundamentals Be Driving The Stock?3 weeks ago | Simply Wall St
How Much Of Nu Skin Enterprises, Inc. (NYSE:NUS) Do Institutions Own?Valuation
Is Nu Skin Enterprises undervalued compared to its fair value and its price relative to the market?
12.9%
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: NUS ($52.99) is trading below our estimate of fair value ($60.85)
Significantly Below Fair Value: NUS is trading below fair value, but not by a significant amount.
Price To Earnings Ratio
PE vs Industry: NUS is good value based on its PE Ratio (14.5x) compared to the US Personal Products industry average (19.9x).
PE vs Market: NUS is good value based on its PE Ratio (14.5x) compared to the US market (22.5x).
Price to Earnings Growth Ratio
PEG Ratio: NUS is poor value based on its PEG Ratio (3.9x)
Price to Book Ratio
PB vs Industry: NUS is good value based on its PB Ratio (3x) compared to the US Personal Products industry average (3.3x).
Future Growth
How is Nu Skin Enterprises forecast to perform in the next 1 to 3 years based on estimates from 4 analysts?
3.7%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: NUS's forecast earnings growth (3.7% per year) is above the savings rate (2%).
Earnings vs Market: NUS's earnings (3.7% per year) are forecast to grow slower than the US market (18.1% per year).
High Growth Earnings: NUS's earnings are forecast to grow, but not significantly.
Revenue vs Market: NUS's revenue (2.9% per year) is forecast to grow slower than the US market (9.3% per year).
High Growth Revenue: NUS's revenue (2.9% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: NUS's Return on Equity is forecast to be low in 3 years time (19.6%).
Past Performance
How has Nu Skin Enterprises performed over the past 5 years?
4.6%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: NUS has high quality earnings.
Growing Profit Margin: NUS's current net profit margins (7.4%) are higher than last year (7.2%).
Past Earnings Growth Analysis
Earnings Trend: NUS's earnings have grown by 4.6% per year over the past 5 years.
Accelerating Growth: NUS's earnings growth over the past year (10.4%) exceeds its 5-year average (4.6% per year).
Earnings vs Industry: NUS earnings growth over the past year (10.4%) underperformed the Personal Products industry 23.8%.
Return on Equity
High ROE: NUS's Return on Equity (21.4%) is considered high.
Financial Health
How is Nu Skin Enterprises's financial position?
Financial Position Analysis
Short Term Liabilities: NUS's short term assets ($903.2M) exceed its short term liabilities ($542.9M).
Long Term Liabilities: NUS's short term assets ($903.2M) exceed its long term liabilities ($519.9M).
Debt to Equity History and Analysis
Debt Level: NUS's debt to equity ratio (37.5%) is considered satisfactory.
Reducing Debt: NUS's debt to equity ratio has increased from 30.3% to 37.5% over the past 5 years.
Debt Coverage: NUS's debt is well covered by operating cash flow (113%).
Interest Coverage: NUS's interest payments on its debt are well covered by EBIT (19.6x coverage).
Balance Sheet
Dividend
What is Nu Skin Enterprises's current dividend yield, its reliability and sustainability?
2.87%
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: NUS's dividend (2.87%) is higher than the bottom 25% of dividend payers in the US market (1.24%).
High Dividend: NUS's dividend (2.87%) is low compared to the top 25% of dividend payers in the US market (3.46%).
Stability and Growth of Payments
Stable Dividend: NUS's dividends per share have been stable in the past 10 years.
Growing Dividend: NUS's dividend payments have increased over the past 10 years.
Current Payout to Shareholders
Dividend Coverage: With its reasonably low payout ratio (41%), NUS's dividend payments are well covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: NUS's dividends in 3 years are forecast to be well covered by earnings (39.8% payout ratio).
Next Steps
Management
How experienced are the management team and are they aligned to shareholders interests?
4.1yrs
Average management tenure
CEO
Ritch Wood (54 yo)
4.08yrs
Tenure
US$4,570,380
Compensation
Mr. Ritch N. Wood has been the Chief Executive Officer of Nu Skin Enterprises, Inc. since March 7, 2017. Mr. Wood served as the Chief Financial Officer at Nu Skin Enterprises Inc. from November 2002 to Mar...
CEO Compensation Analysis
Compensation vs Market: Ritch's total compensation ($USD4.57M) is about average for companies of similar size in the US market ($USD5.13M).
Compensation vs Earnings: Ritch's compensation has been consistent with company performance over the past year.
Leadership Team
Experienced Management: NUS's management team is considered experienced (4.1 years average tenure).
Board Members
Experienced Board: NUS's board of directors are seasoned and experienced ( 10.1 years average tenure).
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: NUS insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Ownership Breakdown
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Company Information
Nu Skin Enterprises, Inc.'s company bio, employee growth, exchange listings and data sources
Key Information
- Name: Nu Skin Enterprises, Inc.
- Ticker: NUS
- Exchange: NYSE
- Founded: 1984
- Industry: Personal Products
- Sector: Household
- Market Cap: US$2.771b
- Shares outstanding: 50.13m
- Website: https://www.nuskin.com
Number of Employees
Location
- Nu Skin Enterprises, Inc.
- 75 West Center Street
- Provo
- Utah
- 84601
- United States
Listings
Biography
Nu Skin Enterprises, Inc. develops and distributes personal care and wellness products worldwide. It provides skin care systems, including ageLOC Me customized skin care and ageLOC Spa systems, and ageLOC ...
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2021/04/17 22:43 |
End of Day Share Price | 2021/04/16 00:00 |
Earnings | 2020/12/31 |
Annual Earnings | 2020/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.